Seeking Alpha

Pfizer (PFE) says it's exercising its right to terminate the license and return three...

Pfizer (PFE) says it's exercising its right to terminate the license and return three development stage products, oxycodone hydrochloride with acetaminophen, hydrocodone bitartrate with acetaminophen and another undisclosed opioid, to Acura Pharmaceutical (ACUR). A fourth product utilizing Acura's AVERSION Technology, Oxecta Tablets CII, is being commercialized, and Pfizer will retain all rights and obligations under the current license agreement.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs